The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients.
Denis O 'MahonyMarie Noelle O'ConnorJoseph EustaceStephen ByrneMirko PetrovicPaul GallagherPublished in: European geriatric medicine (2018)
Neither ADRROP nor the GerontoNet ADR risk scale predicted ADRs to a high level in hospitalized older people with multi-morbidity.